SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia
SARS-CoV-2, the causative agent of the coronavirus disease 2019 (COVID-19), was first identified in December 2019 in Wuhan, China [1]. SARS-CoV-2 was rapidly transmitted globally, disrupting structures and systems; and causing millions of deaths. Globally, there were 278.7M COVID-19 cases and 5.39M attributable deaths by December 2021 [2], 21 months after the World Health Organization (WHO) declared COVID-19 a pandemic [3]. Nigeria reported the first case in Sub-Saharan Africa (SSA) on 28 January 2020 [4].
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Ramatoulie E. Janha, Alasana Bah, Hawanatu Jah, Fatima Touray, Yahaya Idris, Saikou Keita, Yassin Gaye, Samba Jallow, Tisbeh Faye-Joof, Baboucarr Njie, Rachel Craik, Nuredin I. Mohammed, Peter von Dadelszen, Umberto D'Alessandro, Anna Roca, the PRECISE Ne Source Type: research
More News: African Health | China Health | Coronavirus | COVID-19 | Gambia Health | Infectious Diseases | International Medicine & Public Health | Nigeria Health | Pandemics | Pregnancy | SARS | WHO | Women